Scendea
Rob Dow has an extensive work history in the pharmaceutical industry. Rob is currently the Chief Medical Officer at Scendea and a Principal Consultant at Dow Drug Development Solutions Ltd. Previously, they worked as a Drug Development Consultant at Dow Drug Development Consulting. Prior to that, they held multiple roles at PPD Inc, including Chief Medical Officer and Senior Vice President and Global Head, Medical Affairs. Rob also served as the Chief Medical Officer at Cell Genesys and held executive positions at Biolitec Pharma Ltd, Quantanova Ltd, Scotia Holdings Plc, and Hoffmann-La Roche.
Rob Dow attended the University of St Andrews from 1969 to 1972, where they obtained a B.Sc. degree in Medical Science. Following this, they attended the University of Dundee from 1972 to 1975 and received an MB. ChB degree in Medicine.
This person is not in any offices
Scendea
Scendea is a leading product development and regulatory consulting practice serving the pharmaceutical and biotechnology industry. We are committed problem solvers, redefining the meaning of customer service, with a focus on reducing time-to-market and minimising development costs. A combination of scientific excellence, industry experience and a collaborative approach enable us to deliver high-quality innovative solutions, which allow our clients to succeed. Our award-winning international team offers strategic and operational support in the fields of quality/CMC, non-clinical/toxicology, clinical/medical and regulatory, which guide products efficiently from early development to marketing approval.